Viridian Therapeutics
VRDN
#3908
Rank
NZ$5.27 B
Marketcap
NZ$55.23
Share price
-0.44%
Change (1 day)
65.13%
Change (1 year)

Viridian Therapeutics (VRDN) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : NZ$0.12 Billion

According to Viridian Therapeutics's latest financial reports the company's total liabilities are NZ$0.12 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Viridian Therapeutics - Total liabilities on balance sheet (from 2013 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31NZ$0.12 B63.94%
2023-12-31NZ$76.53 M21.4%
2022-12-31NZ$63.04 M169.26%
2021-12-31NZ$23.41 M50.6%
2020-12-31NZ$15.54 M-27.83%
2019-12-31NZ$21.54 M-2.39%
2018-12-31NZ$22.06 M12.18%
2017-12-31NZ$19.67 M197.2%
2016-12-31NZ$6.61 M81.79%
2015-12-31NZ$3.64 M35.98%
2014-12-31NZ$2.67 M-92.02%
2013-12-31NZ$33.53 M13.9%
2012-12-31NZ$29.44 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
ORIC Pharmaceuticals
ORIC
NZ$42.05 M-67.27%๐Ÿ‡บ๐Ÿ‡ธ USA